Centene (CNC) Loses 10% on Flat Medicare Funding

We precocious published 10 Big Names With Painful Declines. Centene Corp. (NYSE:CNC) was 1 of the worst performers connected Tuesday.

Centene Corp. snapped a three-day winning streak connected Tuesday, slashing 10.26 percent to decorativeness astatine $41.53 apiece arsenic investors soured connected the 2027 Medicare Advantage outgo updates, which saw level backing for insurers.

According to the Centers for Medicare and Medicaid Services (CMS), nett mean outgo is projected to summation by lone 0.09 percent, acold little than the 4 to 6 percent maturation arsenic expected by analysts.

Additionally, the CMS projected tighter risk-adjustment rules, specified arsenic excluding diagnoses made lone via audio calls and immoderate chat reviews successful 2027.

The announcement dragged down stock prices of respective listed insurers, including Centene Corp. (NYSE:CNC), UnitedHealth Group, and Oscar Health, among others.

Centene Corp. (NYSE:CNC) is 1 of the starring insurers successful the US, heavy babelike connected government-sponsored programs specified arsenic Medicare, Medicaid, and ACA.

Centene Corp. (NYSE:CNC) is acceptable to merchandise the results of its net show for the 4th fourth and full-year play of 2025 earlier marketplace unfastened connected February 6, 2026. A league telephone volition beryllium held to sermon the results.

Investors volition besides beryllium intimately watching retired for the company’s outlook pursuing updates to the government-sponsored programs.

While we admit the imaginable of CNC arsenic an investment, our condemnation lies successful the content that immoderate AI stocks clasp greater committedness for delivering higher returns and person constricted downside risk. If you are looking for an highly inexpensive AI banal that is besides a large beneficiary of Trump tariffs and onshoring, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.